Adenomyosis Clinical Trials

Find Adenomyosis Clinical Trials Near You

Association of Ultrasound Features of the Myometrium Suggestive of Adenomyosis and Clinical Symptoms (MUSA 3)

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

The goal of this study/research is to assess the relationship between ultrasound features of the myometrium suggestive of adenomyosis and clinical symptoms of adenomyosis and to establish a reporting system for adenomyosis assessing disease severity. Consecutive pre- and perimenopausal symptomatic and asymptomicasymptomatic women with an uterus presenting for gynaecological ultrasound exams will be asked to participate in the study. Routine gynecologicalgynaecological ultrasound exams will be performed and study participants will fill out a questionnaire on their symptoms (if any) and bleeding pattern. There will be one visit and no interventions.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Healthy Volunteers: t
View:

• Women of pre- and perimenopausal age presenting for gynaecologic ultrasound exam giving voluntary informed written consent.

• Symptomatic and asymptomatic women

• Patients with hormonal contraceptives and Hormone Replacement Therapy (HRT) can be included, but information will be noted.

Locations
Other Locations
Poland
Medical University of Silesia
RECRUITING
Sosnowiec
Spain
Hospital Universitari Dexeus
RECRUITING
Barcelona
Switzerland
University Hospital Basel
RECRUITING
Basel
Contact Information
Primary
Gwendolin Manegold-Brauer, Prof. Dr.
gwendolin.manegold-brauer@usb.ch
+41612659046
Backup
Team Swiss GO Trial Group, +41613284203
pm-team@swiss-go.ch
Time Frame
Start Date: 2024-03-15
Estimated Completion Date: 2029-02-01
Participants
Target number of participants: 1000
Treatments
Women with a uterus
Pre - and perimenopausal women with a uterus that are scheduled for a gynaecologic ultrasound exam.
Related Therapeutic Areas
Sponsors
Collaborators: University Hospital, Basel, Switzerland
Leads: Swiss GO Trial Group

This content was sourced from clinicaltrials.gov